Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left"></td><td class="align_left"></td><td class="align_center">BLCA</td><td class="align_center">Normal</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left" rowspan="2">NMP-22 (GICA)</td><td class="align_center">Positive</td><td class="align_center">40</td><td class="align_center">3</td></tr><tr><td class="align_center">Negative</td><td class="align_center">88</td><td class="align_center">91</td></tr><tr><td class="align_left" rowspan="2">Urine cytology</td><td class="align_center">Positive</td><td class="align_center">56</td><td class="align_center">1</td></tr><tr><td class="align_center">Negative</td><td class="align_center">72</td><td class="align_center">93</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Statistics of NMP-22 (GICA) and urine cytology in BLCA patients and normal individuals.</div>

Journal of Immunology Research

tab2

Table 2

Table 2: Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma 